Unichem Laboratories Limited
DSP Mutual Fund increased its stake in Unichem Laboratories from 1.21% to 1.56%, raising its shareholding from 852,063 to 1,100,697 shares. DSP Mutual Fund's Healthcare Fund held 1.6% of Unichem Laboratories as of July 31, 2026.
A pharmaceutical company engaged in the manufacture and distribution of generic medicines, active pharmaceutical ingredients, and contract manufacturing services across multiple therapeutic areas. Unichem Labs operates through an integrated manufacturing infrastructure, serving both domestic and international markets. The company distinguishes itself by offering affordable healthcare solutions while maintaining rigorous quality standards across its diverse product portfolio and manufacturing operations.
Standalone AMC after DSP Group acquired full ownership from BlackRock in 2018. Manages over Rs 1.9 lakh crore. Known for equity funds with a clear process-first culture and minimal star manager dependency. CEO Kalpen Parekh is widely respected for transparent investor communication. DSP Small Cap Fund and DSP Midcap Fund are flagship offerings.